- Appointment of Dr. Jeffrey M. Hills, an orthopedic surgeon specializing in complex spinal conditions
- SMAIO’s Scientific Advisory Board, now comprised of five members, is a key asset in the company’s expansion in the United States
DALLAS & LYON, France–(BUSINESS WIRE)–Regulatory News:
SMAIO (Software, Machines and Adaptative Implants in Orthopaedics – Euronext Growth Paris, ISIN: FR0014005I80 / Ticker: ALSMA), a French-American company specialized in complex spine surgery and offering an integrated pre-, intra- and postoperative solution based on 3D planning software, announces the appointment of Dr. Jeffrey M. Hills, an orthopedic surgeon specializing in complex spinal surgery and Assistant Professor (Clinical) at UT Health San Antonio (Texas), to its North American Scientific Advisory Board.
Dr. Jeffrey M. Hills is a recognized specialist in the field of complex spinal conditions in adults and children. After graduating from the University of Kansas School of Medicine, he completed his residency in orthopedic surgery at Vanderbilt Medical Center in Nashville, Tennessee. He then completed a fellowship in spinal surgery at Washington University School of Medicine / Barnes-Jewish Hospital in St. Louis, Missouri, where he specialized in pediatric and adult spinal deformities as well as complex reconstructive surgeries.
His appointment to the SMAIO Scientific Advisory Board is part of the company’s strategy to build a network of leading experts in the United States, the world’s largest market for spinal surgery. This board contributes in particular to guiding technological developments, the clinical validation of solutions, and the organization of collaborative initiatives and exchange programs among spinal experts, such as the “Sagittal Alignment Think Tanks.”
Dr. Jeffrey M. Hills, an orthopedic surgeon, stated: “Joining SMAIO’s scientific advisory board represents an opportunity to contribute to the development of innovative solutions in spinal surgery. The integration of clinical data and predictive analytics tools is essential to improving patient outcomes. The approach developed by SMAIO, particularly through its open platform, is fully in line with this trend.”
Philippe ROUSSOULY, Chairman and CEO of SMAIO, concluded: “We are very pleased to welcome Dr. Hills to our North American Scientific Advisory Board. His expertise in complex spinal surgery and his interest in data-driven approaches are significant assets that will support our growth in the United States. This appointment underscores our commitment to surrounding ourselves with the best specialists to strengthen our position in this strategic market.”
Dr. Jeffrey M. Hills thus becomes the fifth member of SMAIO’s North American Scientific Advisory Board, joining Dr. Donald J. Blaskiewicz (neurosurgeon at St. Luke’s Clinic in Boise, Idaho), Dr. Brian Neuman (orthopedic surgeon) and Dr. Camilo Molina (neurosurgeon), both practicing at Washington University School of Medicine in St. Louis, Missouri, and Dr. Tenner Guillaume (orthopedic surgeon at Gillette Children’s Hospital in St. Paul, Minnesota).
The terms of remuneration of Dr. Jeffrey M. Hills as a member of the Scientific Advisory Board, mainly in the form of warrants issued to its benefit, are detailed in the appendix to this press release.
About SMAIO
A precursor in the use of clinical data and imaging of the spine, SMAIO designs global solutions for spine surgery specialists. The Company has recognized expertise thanks to its big data database, which has become a global reference with more than 100,000 patient cases documented. SMAIO offers spine surgeons a comprehensive platform, i-Kontrol, incorporating planning, implantable devices and related services, enabling them to treat spinal pathologies in a safe, effective and lasting way. The open platform deployed by the Company in the United States, KEOPS-4ME, is designed to offer a personalized and data-driven approach for complex spine surgeries, enabling SMAIO to enter into commercial partnerships with major US surgical companies and to provide their surgeon customers with patient-specific implants. Based in Dallas (United States) and Lyon (France), SMAIO benefits from the skill and expertise of more than 40 highly specialized employees.
For further information, please visit: www.smaio.com
Listing market: Euronext Growth Paris
ISIN : FR0014005I80
Ticker: ALSMA
Disclaimer
This press release contains non-factual elements, including, but not limited to, certain statements regarding future results and other future events. These statements are based on the current vision and assumptions of the management of the Company. They incorporate known and unknown risks and uncertainties that could result in significant differences in results, profitability and expected events. In addition, SMAIO, its shareholders and affiliates, directors, officers, advisors and employees have not verified the accuracy of, and make no representations or warranties about, the statistical information or forecast information contained in this press release that originates from or is derived from third-party sources or industry publications. Such statistical data and forecast information are used in this press release for information purposes only.
###
Legal Disclaimer:
Content published on SPINEMarketGroup (thespinemarketgroup.com) is provided for informational purposes only and on an “as is” basis, without warranties of any kind. We do not guarantee the accuracy, completeness, legality, or reliability of any information, images, videos, links, or third-party materials featured on the site. Any views or claims expressed in contributed content or press releases belong to their respective authors or sources. For copyright concerns, factual corrections, or content-related complaints, please contact us directly for review.